CLSD icon

Clearside Biomedical
CLSD

Overview Fund Trends Analyst Outlook Journalist POV

46 hedge funds and large institutions have $6.82M invested in Clearside Biomedical in 2023 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 9 increasing their positions, 13 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

less ownership

Funds ownership: →

less funds holding

Funds holding: →

less capital invested

Capital invested by funds: $ → $

31% less repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 13

62% less first-time investments, than exits

New positions opened: 5 | Existing positions closed: 13

Holders
46
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$89K
Puts
$84K
Net Calls
Net Calls Change

Top Buyers

1
+$38.7K
2
+$24K
3
+$22.5K
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$18.8K
5
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services
Minnesota
+$17.4K

Top Sellers

1
-$233K
2
-$123K
3
-$90.5K
4
Renaissance Technologies
Renaissance Technologies
New York
-$55.2K
5
BlackRock
BlackRock
New York
-$43.6K
Name Holding Trade Value Shares
Change 		Change in
Stake
51
–
52
–
53
–
54
–
55
–
56
–
57
–
58
–
59
–
1 2
3